Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke R G Pike

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Neurosurgery|August 30, 2024
Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastasesChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2025
Functional magnetic resonance imaging-guided stereotactic radiosurgery (fMRI-SRS) to avoid symptomatic radionecrosisChengcheng Gui, Mehrnaz Jenabi, Jillian Daly, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
Neurosurgery|March 8, 2024
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body RadiotherapyAssaf Moore, Zhigang Zhang, Teng Fei, et al.
Nature Neuroscience|February 5, 2026
A generalizable foundation model for analysis of human brain MRIDivyanshu Tak, Biniam A Garomsa, Anna Zapaishchykova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
European Urology Oncology|August 6, 2024
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic RadiosurgeryJennifer Ma, Luke Del Balzo, Henry Walch, et al.
Neuro-Oncology|September 2, 2025
Genomics correlates of brain metastasis and progression in colorectal cancerChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Cancer Discovery|June 3, 2024
Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early DetectionPeter J Mazzone, Peter B Bach, Jacob Carey, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Neurosurgery|August 30, 2024
Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastasesChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2025
Functional magnetic resonance imaging-guided stereotactic radiosurgery (fMRI-SRS) to avoid symptomatic radionecrosisChengcheng Gui, Mehrnaz Jenabi, Jillian Daly, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
Neurosurgery|March 8, 2024
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body RadiotherapyAssaf Moore, Zhigang Zhang, Teng Fei, et al.
Nature Neuroscience|February 5, 2026
A generalizable foundation model for analysis of human brain MRIDivyanshu Tak, Biniam A Garomsa, Anna Zapaishchykova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
European Urology Oncology|August 6, 2024
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic RadiosurgeryJennifer Ma, Luke Del Balzo, Henry Walch, et al.
Neuro-Oncology|September 2, 2025
Genomics correlates of brain metastasis and progression in colorectal cancerChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Cancer Discovery|June 3, 2024
Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early DetectionPeter J Mazzone, Peter B Bach, Jacob Carey, et al.
Pageof 7